Heptares, Kymab to develop novel antibody therapeutics in 'perfect marriage,' says CFO
Heptares Therapeutics and Kymab Limited have entered into a strategic collaboration to discover, develop, and commercialize novel antibody therapeutics.
Archives for April 18, 2016
Pluristem in talks with large Japanese firm interested in cell therapy pact
Pluristem is in partnership talks with a large Japanese pharmaceutical firm interested in its cell therapies for hematopoietic diseases.
Shire to construct $400m biologics plant in Ireland; create 400 jobs
Shire says it is investing $400m into a new manufacturing facility in County Meath in the latest boost for the Irish biopharma industry.
Sanofi pumps €300m into Belgian plant to support biologics pipeline
Sanofi will invest €300m ($340m) and create over 100 jobs at a biomanufacturing site in Belgium intended to support its monoclonal antibody pipeline.